Relative bioavailability and pharmacokinetic comparison of a fixed-dose combination tablet of mosapride, pancreatin, and simethicone relative to single-component mosapride tablets in healthy Mexican subjects.

Autor: Camarillo Cárdenas KP; Clinical Pharmacology Department, Avant Santé Research Center S.A. de C.V. Nuevo León, San Pedro Garza García, Mexico., García González J; Clinical Pharmacology Department, Avant Santé Research Center S.A. de C.V. Nuevo León, San Pedro Garza García, Mexico., Argüelles Tello FA; Clinical Pharmacology Department, Avant Santé Research Center S.A. de C.V. Nuevo León, San Pedro Garza García, Mexico., Ocampo Ramírez JA; Established Pharmaceutical Division, Abbott Laboratories de México S.A. de C.V., Ciudad de México, Mexico., Moreno Hernández JB; Established Pharmaceutical Division, Abbott Laboratories de México S.A. de C.V., Ciudad de México, Mexico., Pendela MM; Clinical Pharmacology Department, Avant Santé Research Center S.A. de C.V. Nuevo León, San Pedro Garza García, Mexico.

Publikováno v: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2022 Apr; Vol. 36 (2), pp. 427-435. Date of Electronic Publication: 2021 Dec 08.